| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 6,979,000 | 6,315,000 | 7,336,000 | 9,307,000 | | Cost of Revenue | 5,940,000 | 5,633,000 | 6,651,000 | 7,883,000 | | | Gross Profit | 1,039,000 | 682,000 | 685,000 | 1,424,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 787,000 | 803,000 | 859,000 | 850,000 | | Non Recurring |
-
| 230,000 |
-
| 495,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 252,000 | (351,000) | (174,000) | 79,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (169,000) | (46,000) | (56,000) | 204,000 | | Earnings Before Interest And Taxes | 217,000 | (395,000) | (366,000) | 314,000 | | Interest Expense |
-
|
-
|
-
| 258,000 | | Income Before Tax | 217,000 | (395,000) | (366,000) | 56,000 | | Income Tax Expense | 50,000 | (183,000) | 242,000 | 55,000 | | Minority Interest | (4,000) | 19,000 |
-
| 15,000 | | | | Net Income From Continuing Ops | 163,000 | (193,000) | (608,000) | 16,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 163,000 | (193,000) | (608,000) | 16,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $163,000 | ($193,000) | ($608,000) | $16,000 |
|
0.17% Nasdaq 
Income Statement
